Literature DB >> 14556246

GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region.

Colleen A Morris1, Carolyn B Mervis, Holly H Hobart, Ronald G Gregg, Jacquelyn Bertrand, Gregory J Ensing, Annemarie Sommer, Cynthia A Moore, Robert J Hopkin, Patricia A Spallone, Mark T Keating, Lucy Osborne, Kendra W Kimberley, A Dean Stock.   

Abstract

Most individuals with Williams syndrome (WS) have a 1.6 Mb deletion in chromosome 7q11.23 that encompasses the elastin (ELN) gene, while most families with autosomal dominant supravalvar aortic stenosis (SVAS) have point mutations in ELN. The overlap of the clinical phenotypes of the two conditions (cardiovascular disease and connective tissue abnormalities such as hernias) is due to the effect of haploinsufficiency of ELN. SVAS families often have affected individuals with some WS facial features, most commonly in infancy, suggesting that ELN plays a role in WS facial gestalt as well. To find other genes contributing to the WS phenotype, we studied five families with SVAS who have small deletions in the WS region. None of the families had mental retardation, but affected family members had the Williams Syndrome Cognitive Profile (WSCP). All families shared a deletion of LIMK1, which encodes a protein strongly expressed in the brain, supporting the hypothesis that LIMK1 hemizygosity contributes to impairment in visuospatial constructive cognition. While the deletions from the families nearly spanned the WS region, none had a deletion of FKBP6 or GTF2I, suggesting that the mental retardation seen in WS is associated with deletion of either the centromeric and/or telomeric portions of the region. Comparison of these five families with reports of other individuals with partial deletions of the WS region most strongly implicates GTF2I in the mental retardation of WS. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556246     DOI: 10.1002/ajmg.a.20496

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  69 in total

Review 1.  Methodological issues in group-matching designs: alpha levels for control variable comparisons and measurement characteristics of control and target variables.

Authors:  Carolyn B Mervis; Bonita P Klein-Tasman
Journal:  J Autism Dev Disord       Date:  2004-02

2.  High prevalence of diabetes and pre-diabetes in adults with Williams syndrome.

Authors:  B R Pober; E Wang; S Caprio; K F Petersen; C Brandt; T Stanley; L R Osborne; J Dzuria; B Gulanski
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-05-15       Impact factor: 3.908

3.  Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes.

Authors:  Giuseppe Merla; Cédric Howald; Charlotte N Henrichsen; Robert Lyle; Carine Wyss; Marie-Thérèse Zabot; Stylianos E Antonarakis; Alexandre Reymond
Journal:  Am J Hum Genet       Date:  2006-06-23       Impact factor: 11.025

4.  Children with 7q11.23 duplication syndrome: psychological characteristics.

Authors:  Carolyn B Mervis; Bonita P Klein-Tasman; Myra J Huffman; Shelley L Velleman; C Holley Pitts; Danielle R Henderson; Janet Woodruff-Borden; Colleen A Morris; Lucy R Osborne
Journal:  Am J Med Genet A       Date:  2015-04-21       Impact factor: 2.802

5.  LIMK1 regulates long-term memory and synaptic plasticity via the transcriptional factor CREB.

Authors:  Zarko Todorovski; Suhail Asrar; Jackie Liu; Ner Mu Nar Saw; Krutika Joshi; Miguel A Cortez; O Carter Snead; Wei Xie; Zhengping Jia
Journal:  Mol Cell Biol       Date:  2015-02-02       Impact factor: 4.272

Review 6.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

7.  An atypical 7q11.23 deletion in a normal IQ Williams-Beuren syndrome patient.

Authors:  Giovanni Battista Ferrero; Cédric Howald; Lucia Micale; Elisa Biamino; Bartolomeo Augello; Carmela Fusco; Maria Giuseppina Turturo; Serena Forzano; Alexandre Reymond; Giuseppe Merla
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

Review 8.  Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome.

Authors:  Barbara R Pober; Mark Johnson; Zsolt Urban
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

9.  GTF2IRD2 is located in the Williams-Beuren syndrome critical region 7q11.23 and encodes a protein with two TFII-I-like helix-loop-helix repeats.

Authors:  Aleksandr V Makeyev; Lkhamsuren Erdenechimeg; Ognoon Mungunsukh; Jutta J Roth; Badam Enkhmandakh; Frank H Ruddle; Dashzeveg Bayarsaihan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-08       Impact factor: 11.205

10.  Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension.

Authors:  Miguel Del Campo; Anna Antonell; Luis F Magano; Francisco J Muñoz; Raquel Flores; Mònica Bayés; Luis A Pérez Jurado
Journal:  Am J Hum Genet       Date:  2006-01-31       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.